H2020Индивидуална стипендия2018–2019

NEUROGUIDE · Study of neuronal sensing and migration/guidance dynamics in neurodevelopmental disorders by nano-engineered chips

„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“

Период
2018-03-01 → 2019-03-31
Финансиране от ЕС
96 199 €
Участници
1
Схема
MSCA-IF-EF-ST

Линиите свързват координатора с партньорите.

Накратко на български

Динамиката на движението на невроните се изследва чрез наночипове и модели с мишки, за да се разбере как нивата на протеина UBE3A влияят върху развитието на мозъка. Това помага при разбирането на механизмите зад аутизма и синдрома на Анджелман.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Study of neuronal sensing and migration/guidance dynamics in neurodevelopmental disorders by nano-engineered chips

Defects in neuronal migration have a severe impact on normal brain function. Although deficits in neuronal micro-connectivity are recently emerging as crucial in neurodevelopmental disorders and intellectual disabilities (e.g. autism), the role of neuronal migration processes during brain development is still poorly understood in these pathological conditions. NEUROGUIDE project aims to study neuronal migration/guidance dynamics in neurodevelopmental disorders, with a multidisciplinary approach that combines nano-engineered devices (i.e. nano-structured substrates and microfluidic chips), molecular neuroscience and state-of-the-art fluorescence microscopy. As a pathological model, the project focus on the unbalanced levels of ubiquitin ligase E3a (UBE3A), which leads to several neurodevelopmental disorders. UBE3A has a key role in the brain. In fact, the lack of UBE3A leads to Angelman Syndrome (AS), while its increase is the most prevalent genetic origin of autism (≈ 3%). However, the specific role of UBE3A in brain development is still not known and there is no cure for AS or autistic disorders currently available. These disorders do not only affect the patients but are also a great burden on families and on the healthcare system. NEUROGUIDE project aims to study the neuronal responses to guidance stimuli bi-directionally: 1) in vivo, in Ube3a-mutant mice (using in utero electroporation), to identify if the UBE3A loss/increase impacts neuronal migration and guidance during brain development; 2) in vitro, in Ube3a-mutant neurons by using nano-engineered platforms to apply specific biomimetic environmental physical and/or chemical stimuli to neurons: this approach allows studying the biochemical mechanisms involved in the neuronal guidance processes, at the molecular level (Fig.1). The objectives of NEUROGUIDE project are: - to clarify the role of UBE3A (and its isoforms) in neurodevelopment; - to establish the value of nano-engineered platforms as advanced devices for investigating neuronal guidance dynamics in vitro. These bio-mimicking platforms can be exploited as read-out systems for in vitro testing of novel potential drugs, thus helping in the application of the 3Rs principles.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

Defects in neuronal migration have a severe impact on normal brain function. Here, neuronal contact sensing of the extracellular environment combines with complex signaling, determining the final wiring and plasticity. Although deficits in neuronal micro-connectivity are recently emerging as crucial in neurodevelopmental disorders (e.g. autism, schizophrenia), the role of neuronal sensing and fine-migration processes is still poorly understood in these pathological conditions.I propose to study neuronal sensing and guidance/migration in neurodevelopmental disorders, at both system and molecular level, with a multidisciplinary approach that combines nano-engineered devices (i.e. nano-structured substrates and microfluidic chips), molecular neuroscience and state-of-the-art fluorescence microscopy, with the aim to clarify the biochemical processes impaired in neuronal guidance.As a pathological model, the project will focus on the unbalanced levels of ubiquitin ligase E3a (UBE3A), which leads to several neurodevelopmental disorders. Reduced UBE3A levels result in Angelman Syndrome, whereas increased UBE3A levels results in autism. However, its specific role in brain development is still unclear.This project will investigate the topic of neuronal sensing/guidance bi-directionally: 1) in vivo, in Ube3a-mutant mouse models (using genetic engineered mouse models and/or in utero electroporation with specifically-tagged plasmids or silencing-RNA), to identify deficits; 2) in vitro, in Ube3a-mutant neuronal cells by nano-engineered platforms (by applying specific biomimetic physico-chemical stimuli to single cells), to study the biochemical mechanisms involved in the neuronal guidance deficits.The obtained results will help to clarify the role of UBE3A in the pathogenesis of neurodevelopmental disorders but also to establish the value of nano-engineered platforms as innovative bio-mimicking platforms for investigating neuronal guidance dynamics in vitro, at molecular lev

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз